CLINICAL_TRIALS
trial_result
· 2013-02-12
Clinical Trial Update: Efficacy and Safety of Degarelix One Month Dosing Regimen in Korean Patients With Prostate Cancer [Phase 3]
Summary
A Phase 3 clinical trial update evaluating the efficacy and safety of a one-month degarelix dosing regimen in Korean patients with prostate cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ferring Pharmaceuticals | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2013-02-12